001     157617
005     20240229123141.0
024 7 _ |a 10.1158/0008-5472.CAN-20-0168
|2 doi
024 7 _ |a pmid:32816852
|2 pmid
024 7 _ |a 0008-5472
|2 ISSN
024 7 _ |a 0099-7013
|2 ISSN
024 7 _ |a 0099-7374
|2 ISSN
024 7 _ |a 1538-7445
|2 ISSN
024 7 _ |a altmetric:88651874
|2 altmetric
037 _ _ |a DKFZ-2020-01714
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Hidaka, Akihisa
|0 0000-0002-1772-8159
|b 0
245 _ _ |a Intake of dietary fruit, vegetables, and fiber and risk of colorectal cancer according to molecular subtypes: A pooled analysis of 9 studies.
260 _ _ |a Philadelphia, Pa.
|c 2020
|b AACR
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1606142696_9693
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2020 Oct 15;80(20):4578-4590
520 _ _ |a Protective associations of fruits, vegetables, and fiber intake with colorectal cancer (CRC) risk have been shown in many, but not all epidemiological studies. One possible reason for study heterogeneity is that dietary factors may have distinct effects by CRC molecular subtypes. Here we investigate the association of fruit, vegetables, and fiber intake with four well-established CRC molecular subtypes separately and in combination. Nine observational studies including 9,592 cases with molecular subtypes for microsatellite instability (MSI), CpG island methylator phenotype (CIMP), and somatic mutations in BRAF and KRAS genes, and 7,869 controls were analyzed. Both case-only logistic regression analyses and polytomous logistic regression analyses (with one control set and multiple case groups) were used. Higher fruit intake was associated with a trend towards decreased risk of BRAF-mutated tumors [Odds ratio 4th vs. 1st quartile = 0.82 (95% confidence interval = 0.65-1.04)] but not BRAF-wildtype tumors [1.09 (0.97-1.22); P-difference as shown in case-only analysis = 0.02]. This difference was observed in case-control studies and not in cohort studies. Compared with controls, higher fiber intake showed negative association with CRC risk for cases with microsatellite stable (MSS)/MSI-low, CIMP-negative, BRAF-wildtype, and KRAS-wildtype tumors (Ptrend range from 0.03 to 3.4e-03), which is consistent with the traditional adenoma-CRC pathway. These negative associations were stronger compared with MSI-high, CIMP-positive, BRAF-mutated, or KRAS-mutated tumors, but the differences were not statistically significant. These inverse associations for fruit and fiber intake may explain, in part, inconsistent findings between fruit or fiber intake and CRC risk that have previously been reported.
536 _ _ |a 313 - Cancer risk factors and prevention (POF3-313)
|0 G:(DE-HGF)POF3-313
|c POF3-313
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Harrison, Tabitha A
|0 0000-0002-4173-7530
|b 1
700 1 _ |a Cao, Yin
|b 2
700 1 _ |a Sakoda, Lori C
|0 0000-0002-0900-5735
|b 3
700 1 _ |a Barfield, Richard
|b 4
700 1 _ |a Giannakis, Marios
|b 5
700 1 _ |a Song, Mingyang
|b 6
700 1 _ |a Phipps, Amanda I
|b 7
700 1 _ |a Figueiredo, Jane C
|b 8
700 1 _ |a Zaidi, Syed H
|b 9
700 1 _ |a Toland, Amanda E
|b 10
700 1 _ |a Amitay, Efrat
|0 P:(DE-He78)6e02c183f41e45a5867dec393fb4616a
|b 11
|u dkfz
700 1 _ |a Berndt, Sonja I
|b 12
700 1 _ |a Borozan, Ivan
|b 13
700 1 _ |a Chan, Andrew T
|b 14
700 1 _ |a Gallinger, Steven
|b 15
700 1 _ |a Gunter, Marc J
|b 16
700 1 _ |a Guinter, Mark A
|0 0000-0001-5547-7795
|b 17
700 1 _ |a Harlid, Sophia
|0 0000-0001-8540-6891
|b 18
700 1 _ |a Hampel, Heather
|0 0000-0001-7558-9794
|b 19
700 1 _ |a Jenkins, Mark A
|b 20
700 1 _ |a Lin, Yi
|b 21
700 1 _ |a Moreno, Victor
|0 0000-0002-2818-5487
|b 22
700 1 _ |a Newcomb, Polly A
|b 23
700 1 _ |a Nishihara, Reiko
|b 24
700 1 _ |a Ogino, Shuji
|0 0000-0002-3909-2323
|b 25
700 1 _ |a Obón-Santacana, Mireia
|b 26
700 1 _ |a Parfrey, Patrick S
|b 27
700 1 _ |a Potter, John D
|0 0000-0001-5439-1500
|b 28
700 1 _ |a Slattery, Martha L
|0 0000-0002-1655-6543
|b 29
700 1 _ |a Steinfelder, Robert S
|b 30
700 1 _ |a Um, Caroline Y
|0 0000-0001-5449-6230
|b 31
700 1 _ |a Wang, Xiaoliang
|b 32
700 1 _ |a Woods, Michael O
|b 33
700 1 _ |a Van Guelpen, Bethany
|0 0000-0002-9692-101X
|b 34
700 1 _ |a Thibodeau, Stephen N
|b 35
700 1 _ |a Hoffmeister, Michael
|0 P:(DE-He78)6c5d058b7552d071a7fa4c5e943fff0f
|b 36
|u dkfz
700 1 _ |a Sun, Wei
|0 0000-0002-6350-1107
|b 37
700 1 _ |a Hsu, Li
|b 38
700 1 _ |a Buchanan, Daniel D
|0 0000-0003-2225-6675
|b 39
700 1 _ |a Campbell, Peter T
|b 40
700 1 _ |a Peters, Ulrike
|b 41
773 _ _ |a 10.1158/0008-5472.CAN-20-0168
|g p. canres.0168.2020 -
|0 PERI:(DE-600)2036785-5
|n 20
|p 4578-4590
|t Cancer research
|v 80
|y 2020
|x 1538-7445
909 C O |o oai:inrepo02.dkfz.de:157617
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 11
|6 P:(DE-He78)6e02c183f41e45a5867dec393fb4616a
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 36
|6 P:(DE-He78)6c5d058b7552d071a7fa4c5e943fff0f
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-313
|2 G:(DE-HGF)POF3-300
|v Cancer risk factors and prevention
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2020
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2020-01-12
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CANCER RES : 2018
|d 2020-01-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2020-01-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
|d 2020-01-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2020-01-12
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2020-01-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2020-01-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2020-01-12
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
|d 2020-01-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2020-01-12
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
|d 2020-01-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2020-01-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2020-01-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2020-01-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2020-01-12
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b CANCER RES : 2018
|d 2020-01-12
920 1 _ |0 I:(DE-He78)C070-20160331
|k C070
|l C070 Klinische Epidemiologie und Alternf.
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C070-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21